Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Journal of Clinical Medicine|February 13, 2025
Role of Mirikizumab in the Treatment of Inflammatory Bowel Disease-From Bench to BedsideMichael Colwill, Samantha Baillie, Jennifer Clough, et al.Journal of Crohn'S & Colitis|March 30, 2024
Magnetic Resonance Enterography and Intestinal Ultrasound for the Assessment and Monitoring of Crohn's DiseaseShankar Kumar, Isabelle De Kock, William Blad, et al.Journal of Gastroenterology and Hepatology|August 30, 2014
Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn's disease: correlation with intraoperative findings and magnetic resonance enterographyShankar Kumar, Aishah Hakim, Christopher Alexakis, et al.Journal of Clinical Medicine|May 27, 2023
Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel DiseaseIago Rodríguez-Lago, Jonathan Blackwell, Beatriz Mateos, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Comparison of small intestinal contrast ultrasound with magnetic resonance enterography in pediatric Crohn's diseaseAishah Hakim, Christopher Alexakis, James Pilcher, et al.Frontline Gastroenterology|March 15, 2024
JAK inhibitors for inflammatory bowel disease: recent advancesSailish Honap, Alexandra Agorogianni, Michael J Colwill, et al.BMC Health Services Research|July 9, 2026
Addressing real-world data gaps: estimating the uk population cost of crohn's disease and ulcerative colitis using a flexible cost-of-illness model informed by the optimal patient journey and IBDUK patient survey 2023Rachael MacDonald, Nick Hex, Barbara Uzdzinska, et al.Journal of Crohn'S & Colitis|December 10, 2024
Modifiable Psychological Factors are Associated With Clusters of Pain, Fatigue, Fecal Incontinence, and Irritable Bowel Syndrome-Type Symptoms in Inflammatory Bowel Disease: A Latent Profile AnalysisVari Wileman, Joseph Chilcot, Christine Norton, et al.World Journal of Gastrointestinal Pharmacology and Therapeutics|December 11, 2025
Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary centerMichael Colwill, Jessica Padley, Umang Qazi, et al.Journal of Clinical Medicine|October 13, 2021
Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World StudyKonstantina Rosiou, Elaine Ong Ming San, Aditi Kumar, et al.Pageof 5